Top Institutions in Ophthalmology - Glaucoma Therapeutics
Institutions are ranked based on their leadership in glaucoma research, clinical trials involving novel pharmacologic agents such as rho kinase inhibitors and EVP-targeting drugs, and innovation in sustained-release drug delivery systems for glaucoma management.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in glaucoma research and clinical trials, pioneering novel therapies including sustained-release drug delivery and EVP-targeting agents. Their affiliation with Harvard Medical School enhances their translational research capabilities.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is renowned for its comprehensive glaucoma program and active involvement in cutting-edge clinical trials for new glaucoma drugs and surgical techniques, including research on episcleral venous pressure modulation.
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a strong glaucoma research division focused on new medical therapies and understanding pathophysiology including EVP's role in glaucoma, contributing to early clinical trials of innovative agents.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in glaucoma research with a focus on innovative medical therapies and the vascular mechanisms underlying glaucoma, including EVP modulation and neuroprotection.
-
#5
Duke University Eye Center
Durham, NC
Duke Eye Center has a robust glaucoma research program with expertise in pharmacologic innovation and sustained-release drug delivery systems, contributing to early phase trials of EVP-targeting agents.